Amantadine – A Fatigue Reducer for Long COVID and ME/CFS?
It seems a bit odd that we haven’t heard much about amantadine (Gocovri, Symadine, and Symmetrel) in chronic fatigue syndrome (ME/CFS) or long COVID. They are, after all, the two big fatiguing diseases on the planet, and amantadine is the go-to drug for fatigue...
A Bad Blood Vessel – Neuroinflammation Connection Shows Up in Long COVID
The brain and the blood vessels. So intimately intertwined but so rarely studied together. In retrospect, that’s kind of strange as blood vessels may have more to do with brain functioning than anything else. By weight, the brain is almost a non-entity –...
Lifting ME/CFS: The OMF’s Unique Two-Drug Clinical Trial to Begin Soon
Filling a Gaping Hole ME/CFS organizations have been doing something different lately. Long focused purely on research, they’ve been putting more resources into treatment trials lately – suggesting they feel more confident about moving forward in that...
The Dan Neuffer Interview on Recovery From ME/CFS and Fibromyalgia Pt. II – Broad Themes and Why He’s Stopped Counting Recovery Stories
In Pt. II of our 4-part interview on how people with chronic fatigue syndrome (ME/CFS) and fibromyalgia (FM) recover, we cover the following topics. I ask what did CFS Unravelled bring that was new – a single explanation 0:00:22 Dan challenges the model of...
Surprising Findings Dot Day 2 of the Keystone Long-COVID Conference
We continue to take a deep dive into the “Long COVID and Post Acute Sequalae of SARS CoV 2 (PASC): Pathogenesis and Treatment” first-ever international conference on long COVID. Long-COVID research was always going to be a bit messy. Take a look at the...Lives Interrupted Latest Story
Allyn Archer
Atlanta, United States
Former occupation: Architect, Professor of Architecture
$2,768,291
StudyME
Enroll in the OMF’s StudyME project and help bring about a cure for ME/CFS, fibromyalgia, POTS and long COVID.
